GSK548470
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK548470, covering 2013-10-29 to 2013-11-04. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs [Phase 3]